Terms: = Colorectal cancer AND MSN, P26038, 4478, ENSG00000147065 AND Treatment
9 results:
1. Reactive Oxygen Species-Sensitive Biodegradable Mesoporous Silica Nanoparticles Harboring TheraVac Elicit Tumor-Specific Immunity for Colon Tumor treatment.
Huang Y; Nahar S; Alam MM; Hu S; McVicar DW; Yang D
ACS Nano; 2023 Oct; 17(20):19740-19752. PubMed ID: 37831945
[TBL] [Abstract] [Full Text] [Related]
2. [Manganese-based nanoparticles for chemodynamic therapy of gastrointestinal cancer].
Lin X; Huang M; Chen J; Zhou X; Zhong Z; Lu W; Huang X; Liu T
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Aug; 43(8):1432-1439. PubMed ID: 37712282
[TBL] [Abstract] [Full Text] [Related]
3. Identification of Moesin (msn) as a Potential Therapeutic Target for colorectal cancer via the β-Catenin-RUNX2 Axis.
Huang CY; Wei PL; Batzorig U; Makondi PT; Lee CC; Chang YJ
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446127
[TBL] [Abstract] [Full Text] [Related]
4. In situ-activated photothermal nanoplatform for on-demand NO gas delivery and enhanced colorectal cancer treatment.
Xin Y; Yu Y; Su M; Li X; Elsabahy M; Gao H
J Control Release; 2023 Jul; 359():69-84. PubMed ID: 37245723
[TBL] [Abstract] [Full Text] [Related]
5. Biofilm-encapsulated nano drug delivery system for the treatment of colon cancer.
Shi J; Ma Z; Pan H; Liu Y; Chu Y; Wang J; Chen L
J Microencapsul; 2020 Nov; 37(7):481-491. PubMed ID: 32700606
[TBL] [Abstract] [Full Text] [Related]
6. MiRNA-204-5p and oxaliplatin-loaded silica nanoparticles for enhanced tumor suppression effect in CD44-overexpressed colon adenocarcinoma.
Yang H; Liu Y; Qiu Y; Ding M; Zhang Y
Int J Pharm; 2019 Jul; 566():585-593. PubMed ID: 31181310
[TBL] [Abstract] [Full Text] [Related]
7. Galactosylated Chitosan-Functionalized Mesoporous Silica Nanoparticle Loading by Calcium Leucovorin for Colon cancer Cell-Targeted Drug Delivery.
Liu W; Wang F; Zhu Y; Li X; Liu X; Pang J; Pan W
Molecules; 2018 Nov; 23(12):. PubMed ID: 30486276
[TBL] [Abstract] [Full Text] [Related]
8. Mesoporous silica nanoparticles (msns)-based organic/inorganic hybrid nanocarriers loading 5-Fluorouracil for the treatment of colon cancer with improved anticancer efficacy.
Pan G; Jia TT; Huang QX; Qiu YY; Xu J; Yin PH; Liu T
Colloids Surf B Biointerfaces; 2017 Nov; 159():375-385. PubMed ID: 28818782
[TBL] [Abstract] [Full Text] [Related]
9. ROS1 protein-tyrosine kinase inhibitors in the treatment of ROS1 fusion protein-driven non-small cell lung cancers.
Roskoski R
Pharmacol Res; 2017 Jul; 121():202-212. PubMed ID: 28465216
[TBL] [Abstract] [Full Text] [Related]
